(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are ADOCIA, BOUSSARD GAVAUDAN, and IDEX BIOMETRICS.

Financial Asset	Price	Change	Updated (EST)
ADOCIA (ADOC.PA)	5.00	12.23%	2023-07-25 11:35:59
BOUSSARD GAVAUDAN (BGHL.AS)	23.80	11.21%	2023-07-25 08:01:16
IDEX BIOMETRICS (IDEX.OL)	0.74	10.51%	2023-07-25 11:30:38
BASIC-FIT (BFIT.AS)	34.00	7.66%	2023-07-25 11:01:08
NEPI ROCKCASTLE (NRP.AS)	5.80	7.41%	2023-07-25 11:03:55
SODITECH (SEC.PA)	1.50	7.14%	2023-07-25 11:03:59
OCEANTEAM (OTS.OL)	1.70	6.27%	2023-07-25 11:32:11
BIOSENIC (BIOS.BR)	0.07	6.11%	2023-07-25 08:06:14
PCAS (PCA.PA)	7.55	5.59%	2023-07-25 08:01:28
PB HOLDING (PBH.AS)	3.22	5.57%	2023-07-25 11:04:14

The three biggest losers today are CUMULEX, ADC SIIC, and SOC FRANC CASINOS.

Financial Asset	Price	Change	Updated (EST)
CUMULEX (CLEX.BR)	1.84	-18.58%	2023-07-25 11:07:05
ADC SIIC (ALDV.PA)	0.05	-14.29%	2023-07-25 11:35:51
SOC FRANC CASINOS (SFCA.PA)	1.88	-11.32%	2023-07-25 11:03:43
SAINT JEAN GROUPE (SABE.PA)	19.70	-10.45%	2023-07-25 11:02:47
GROUPE JAJ (GJAJ.PA)	1.31	-9.03%	2023-07-25 08:50:14
CASINO GUICHARD (CO.PA)	3.10	-8.82%	2023-07-25 11:46:03
ELIOR GROUP (ELIOR.PA)	2.60	-8.39%	2023-07-25 11:48:04
NANOBIOTIX (NANO.PA)	7.94	-7.03%	2023-07-25 11:00:41
COHERIS (COH.PA)	5.10	-6.42%	2023-07-25 11:46:38
ACOMO (ACOMO.AS)	20.80	-6.31%	2023-07-25 08:00:11

Winners today

1. ADOCIA (ADOC.PA)

12.23% Price Change

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; BioChaperone LisPram, a combination of prandial insulin with pramlintide; and BioChaperone Glucagon, an aqueous formulation of human glucagon for the treatment of hypoglycemia, as well as M1Pram, a metabolite of insulin glargine and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and BioChaperone GluExe, a combination of glucagon and exenatide. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.

CAC 40 ended the session with ADOCIA rising 12.23% to €5.00 on Tuesday while CAC 40 fell 0.16% to €7,415.45.

Earnings Per Share

As for profitability, ADOCIA has a trailing twelve months EPS of €-0.93.

Yearly Top and Bottom Value

ADOCIA’s stock is valued at €5.00 at 22:40 EST, way below its 52-week high of €5.60 and way higher than its 52-week low of €2.75.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ADOCIA’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for ADOCIA is 210893 which is 159.09% above its average volume of 81395.

More news about ADOCIA.

2. BOUSSARD GAVAUDAN (BGHL.AS)

11.21% Price Change

Boussard & Gavaudan Holding Limited is a closed-ended balanced fund of funds launched and managed by Boussard & Gavaudan Asset Management, LP. It invests in a fund which invests in public equity and fixed income markets across the globe. The fund seeks to invest in securities of companies operating across diversified sectors. It primarily invests in units of BG Umbrella Fund Plc – BG Fund, a feeder fund to BG Master Fund Plc, which in turn invests in value stocks of companies and fixed income securities. The fund employs both fundamental and quantitative analysis with a bottom-up security selection approach to create its portfolio. It employs multiple strategies including convertible bond arbitrage, volatility arbitrage, gamma trading, merger arbitrage, special situations, equity long/short, value, capital structure arbitrage, credit long/short, and restructuring/distressed securities strategies to make its investments. Boussard & Gavaudan Holding Limited was formed on October 3, 2006 and is domiciled in the Channel Islands.

AEX-Index ended the session with BOUSSARD GAVAUDAN jumping 11.21% to €23.80 on Tuesday while AEX-Index jumped 1.07% to €779.81.

Earnings Per Share

As for profitability, BOUSSARD GAVAUDAN has a trailing twelve months EPS of €2.73.

PE Ratio

BOUSSARD GAVAUDAN has a trailing twelve months price to earnings ratio of 8.71. Meaning, the purchaser of the share is investing €8.71 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.21%.

Moving Average

BOUSSARD GAVAUDAN’s value is higher than its 50-day moving average of €21.81 and above its 200-day moving average of €22.17.

Volume

Today’s last reported volume for BOUSSARD GAVAUDAN is 119421 which is 3623.76% above its average volume of 3207.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BOUSSARD GAVAUDAN’s stock is considered to be overbought (>=80).

Yearly Top and Bottom Value

BOUSSARD GAVAUDAN’s stock is valued at €23.80 at 22:40 EST, under its 52-week high of €24.00 and way above its 52-week low of €21.40.

More news about BOUSSARD GAVAUDAN.

3. IDEX BIOMETRICS (IDEX.OL)

10.51% Price Change

IDEX Biometrics ASA, together with its subsidiaries, designs, develops, and sells fingerprint authentication solutions in Norway, Europe, the Middle East, Africa, the Americas, and the Asia-Pacific regions. The company's fingerprint authentication solutions are used primarily in contactless financial payment, access control, and smart cards, as well as card-based devices for the storage of digital currencies. It primarily serves manufacturers of smart cards for financial payment applications and biometric payment card markets. The company was incorporated in 1996 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with IDEX BIOMETRICS rising 10.51% to €0.74 on Tuesday, after two successive sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.45% to €1,242.70, after five successive sessions in a row of gains, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, IDEX BIOMETRICS has a trailing twelve months EPS of kr-0.29.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -135.19%.

Volume

Today’s last reported volume for IDEX BIOMETRICS is 13176500 which is 88.33% above its average volume of 6996360.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, IDEX BIOMETRICS’s stock is considered to be overbought (>=80).

More news about IDEX BIOMETRICS.

4. BASIC-FIT (BFIT.AS)

7.66% Price Change

Basic-Fit N.V., together with its subsidiaries, engages in the operation of fitness clubs. It operates 1200 clubs under Basic-Fit brand in Netherlands, Belgium, Luxembourg, Germany, France, and Spain. The company was founded in 1984 and is headquartered in Hoofddorp, the Netherlands.

AEX-Index ended the session with BASIC-FIT rising 7.66% to €34.00 on Tuesday, after five sequential sessions in a row of losses. AEX-Index jumped 1.07% to €779.81, following the last session’s downward trend on what was an all-around bullish trend exchanging session today.

Earnings Per Share

As for profitability, BASIC-FIT has a trailing twelve months EPS of €-0.06.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.9%.

Yearly Top and Bottom Value

BASIC-FIT’s stock is valued at €34.00 at 22:40 EST, way below its 52-week high of €43.08 and way above its 52-week low of €21.66.

Sales Growth

BASIC-FIT’s sales growth is negative 53.4% for the current quarter and negative 56.2% for the next.

Volatility

BASIC-FIT’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.02%, a negative 0.18%, and a positive 1.36%.

BASIC-FIT’s highest amplitude of average volatility was 1.02% (last week), 1.51% (last month), and 1.36% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 52.9%, now sitting on 794.57M for the twelve trailing months.

More news about BASIC-FIT.

5. NEPI ROCKCASTLE (NRP.AS)

7.41% Price Change

NEPI Rockcastle is the premier owner and operator of shopping centres in Central and Eastern Europe (CEE), with presence in nine countries and an investment portfolio of €5.8 billion as at 31 December 2021. The Group benefits from a highly-skilled internal management team which combines asset management, development, investment, leasing and financial expertise. Geographically diverse management skills allow NEPI Rockcastle to pursue CEE property opportunities efficiently, benefiting from a strategic advantage in the acquisition, development and management of properties. NEPI Rockcastle owns and operates 52 retail properties (excluding joint venture) which attracted 244 million visits in 2021 (325 million visits in 2019). With group-level management of tenant relationships and a focus on cross-country collaboration, the Group is the leading strategic partner for major retailers targeting CEE countries. The Group's financial strategy includes maintaining a profile of adequate liquidity, conservative gearing, and a diverse debt structure, which combines secured and unsecured bank debt with unsecured bonds listed on the Irish Stock Exchange. NEPI Rockcastle is investment-grade rated by Standard & Poor's (BBB, stable outlook) and Fitch (BBB, positive outlook). NEPI Rockcastle's shares are listed on the Johannesburg Stock Exchange (“JSE”), Euronext Amsterdam (“Euronext”) and A2X. The Group voluntarily distributes at least 90% of its distributable earnings on a semi-annual basis.

AEX-Index ended the session with NEPI ROCKCASTLE rising 7.41% to €5.80 on Tuesday, after four sequential sessions in a row of losses. AEX-Index jumped 1.07% to €779.81, following the last session’s downward trend on what was an all-around up trend exchanging session today.

Earnings Per Share

As for profitability, NEPI ROCKCASTLE has a trailing twelve months EPS of €0.71.

PE Ratio

NEPI ROCKCASTLE has a trailing twelve months price to earnings ratio of 8.17. Meaning, the purchaser of the share is investing €8.17 for every euro of annual earnings.

Volume

Today’s last reported volume for NEPI ROCKCASTLE is 16 which is 99.02% below its average volume of 1635.

More news about NEPI ROCKCASTLE.

6. SODITECH (SEC.PA)

7.14% Price Change

Soditech SA engages in the integration of mechanical, thermal, and electronic sub-assemblies in space, research, and defense fields in France. It designs structural sub-assemblies and integrates optical and thermal equipment, such as OSRs, SSMs, heaters, and heat pipes; designs and manufactures multi-layer insulation products; and designs, manufactures, and tests space harnesses on instruments or platforms. The company also provides calculation services, such as static, dynamic, thermal, and thermoelastic; designs assembly tools; and designs and produces super insulating multi-layer mattresses for ultra-vacuum areas. In addition, it develops, qualifies, manufactures, and tests embedded cabinets; and designs, assembles, and tests racks and test equipment racks. The company was formerly known as Soditech Ingenierie SA. Soditech SA was founded in 1990 and is headquartered in Aix-en-Provence, France.

CAC 40 ended the session with SODITECH rising 7.14% to €1.50 on Tuesday while CAC 40 fell 0.16% to €7,415.45.

Earnings Per Share

As for profitability, SODITECH has a trailing twelve months EPS of €0.12.

PE Ratio

SODITECH has a trailing twelve months price to earnings ratio of 12.5. Meaning, the purchaser of the share is investing €12.5 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.54%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 12.7%, now sitting on 4.59M for the twelve trailing months.

Moving Average

SODITECH’s value is under its 50-day moving average of €1.54 and above its 200-day moving average of €1.48.

More news about SODITECH.

7. OCEANTEAM (OTS.OL)

6.27% Price Change

Oceanteam ASA operates as a subsea and offshore services company in Europe. It provides equipment for offshore cable laying, umbilical installations, and on- and offshore storage and transport. The company also rents turntables, tensioners, reels, demountable turntable systems, and other cable handling and storage equipment, as well as offers cable and umbilical storage, and handling solutions. It serves renewable energy, and oil and gas industries. The company was formerly known as Oceanteam Shipping ASA and changed its name to Oceanteam ASA in December 2015. Oceanteam ASA was incorporated in 2005 and is headquartered in Bærum, Norway.

Oslo Børs Benchmark Index_GI ended the session with OCEANTEAM rising 6.27% to €1.70 on Tuesday while Oslo Børs Benchmark Index_GI jumped 0.45% to €1,242.70.

Earnings Per Share

As for profitability, OCEANTEAM has a trailing twelve months EPS of kr-0.31.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.42%.

Volume

Today’s last reported volume for OCEANTEAM is 3400 which is 91.47% below its average volume of 39893.

Volatility

OCEANTEAM’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.20%, a negative 0.31%, and a positive 4.02%.

OCEANTEAM’s highest amplitude of average volatility was 2.39% (last week), 4.07% (last month), and 4.02% (last quarter).

More news about OCEANTEAM.

8. BIOSENIC (BIOS.BR)

6.11% Price Change

BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures' and ArsciCor, which is in Phase III in GvHD is being prepared with an oral treatment. BioSenic S.A. is based in Mont-Saint-Guibert, Belgium.

BEL 20 ended the session with BIOSENIC rising 6.11% to €0.07 on Tuesday while BEL 20 rose 0.73% to €3,815.25.

Earnings Per Share

As for profitability, BIOSENIC has a trailing twelve months EPS of €-0.02.

Volume

Today’s last reported volume for BIOSENIC is 11504 which is 94.53% below its average volume of 210532.

Volatility

BIOSENIC’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.77%, a negative 2.00%, and a positive 4.47%.

BIOSENIC’s highest amplitude of average volatility was 7.51% (last week), 4.07% (last month), and 4.47% (last quarter).

More news about BIOSENIC.

9. PCAS (PCA.PA)

5.59% Price Change

PCAS SA develops and produces complex molecules for life sciences and technologies. The company was founded in 1962 and is headquartered in Longjumeau, France. PCAS SA is a subsidiary of Seqens SAS

CAC 40 ended the session with PCAS rising 5.59% to €7.55 on Tuesday, following the last session’s downward trend. CAC 40 dropped 0.16% to €7,415.45, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, PCAS has a trailing twelve months EPS of €-3.51.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -967.35%.

Moving Average

PCAS’s value is higher than its 50-day moving average of €7.45 and higher than its 200-day moving average of €7.06.

More news about PCAS.

10. PB HOLDING (PBH.AS)

5.57% Price Change

PB Holding N.V. provides financial services. The company was formerly known as Stern Groep N.V. and changed its name to PB Holding N.V. in March 2022. PB Holding N.V. is headquartered in Amsterdam, the Netherlands.

AEX-Index ended the session with PB HOLDING rising 5.57% to €3.22 on Tuesday, following the last session’s downward trend. AEX-Index jumped 1.07% to €779.81, following the last session’s downward trend on what was an all-around up trend exchanging session today.

Earnings Per Share

As for profitability, PB HOLDING has a trailing twelve months EPS of €0.02.

PE Ratio

PB HOLDING has a trailing twelve months price to earnings ratio of 161. Meaning, the purchaser of the share is investing €161 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.98%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, PB HOLDING’s stock is considered to be overbought (>=80).

More news about PB HOLDING.

Losers Today

1. CUMULEX (CLEX.BR)

-18.58% Price Change

Cumulex N.V. does not have significant operations. Previously, the company was engaged in sugar plantation business in the Democratic Republic of Congo. The company was formerly known as Sucrerie et Raffinerie de l'Afrique Centrale NV and changed its name to Cumulex N.V. in March 2021. The company was founded in 1956 and is based in Diegem, Belgium. Cumulex N.V. is a subsidiary of Value8 NV.

BEL 20 ended the session with CUMULEX sliding 18.58% to €1.84 on Tuesday, after five consecutive sessions in a row of losses. BEL 20 jumped 0.73% to €3,815.25, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, CUMULEX has a trailing twelve months EPS of €-0.21.

More news about CUMULEX.

2. ADC SIIC (ALDV.PA)

-14.29% Price Change

Alliance Developpement Capital SIIC (ADC SIIC) is a publicly owned real estate investment firm. The firm specializes in owning and managing residential real estate properties. It primarily invests in properties in Paris and its suburbs. The firm was formerly known as AD Capital SA. Alliance Developpement Capital is based in Saint-Josse-Ten-Noode, Belgium.

CAC 40 ended the session with ADC SIIC sliding 14.29% to €0.05 on Tuesday while CAC 40 fell 0.16% to €7,415.45.

Earnings Per Share

As for profitability, ADC SIIC has a trailing twelve months EPS of €-0.01.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.87%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 351.3%, now sitting on 1.01M for the twelve trailing months.

More news about ADC SIIC.

3. SOC FRANC CASINOS (SFCA.PA)

-11.32% Price Change

Société Française de Casinos Société Anonyme operates casinos in France. The company is also involved in the hotel and restaurant activities. The company is based in Paris, France.

CAC 40 ended the session with SOC FRANC CASINOS dropping 11.32% to €1.88 on Tuesday while CAC 40 dropped 0.16% to €7,415.45.

Earnings Per Share

As for profitability, SOC FRANC CASINOS has a trailing twelve months EPS of €0.35.

PE Ratio

SOC FRANC CASINOS has a trailing twelve months price to earnings ratio of 5.37. Meaning, the purchaser of the share is investing €5.37 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.61%.

Yearly Top and Bottom Value

SOC FRANC CASINOS’s stock is valued at €1.88 at 22:40 EST, way below its 52-week high of €2.10 and way above its 52-week low of €1.42.

Volume

Today’s last reported volume for SOC FRANC CASINOS is 378 which is 281.81% above its average volume of 99.

Volatility

SOC FRANC CASINOS’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.42%, a negative 3.27%, and a positive 6.80%.

SOC FRANC CASINOS’s highest amplitude of average volatility was 4.42% (last week), 5.00% (last month), and 6.80% (last quarter).

More news about SOC FRANC CASINOS.

4. SAINT JEAN GROUPE (SABE.PA)

-10.45% Price Change

Saint Jean Groupe Société anonyme, through its subsidiaries, operates in the agri-food sector in France. The company offers ravioles, dumplings, fresh pasta, and delicatessen products under the Saint, Royans, Ravioles de Romans, Quenelles La Royale, and Comptoir du Pastier brand names. The company is headquartered in Dardilly, France.

CAC 40 ended the session with SAINT JEAN GROUPE falling 10.45% to €19.70 on Tuesday while CAC 40 fell 0.16% to €7,415.45.

Earnings Per Share

As for profitability, SAINT JEAN GROUPE has a trailing twelve months EPS of €0.18.

PE Ratio

SAINT JEAN GROUPE has a trailing twelve months price to earnings ratio of 109.44. Meaning, the purchaser of the share is investing €109.44 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.81%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 13.1%, now sitting on 104.5M for the twelve trailing months.

Volume

Today’s last reported volume for SAINT JEAN GROUPE is 23 which is 86.47% below its average volume of 170.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SAINT JEAN GROUPE’s stock is considered to be oversold (<=20).

More news about SAINT JEAN GROUPE.

5. GROUPE JAJ (GJAJ.PA)

-9.03% Price Change

Groupe JAJ distributes clothing products. It offers clothing products of the SCHOTT brand. The company was formerly known as JAJ Distribution. The company is headquartered in Montreuil, France.

CAC 40 ended the session with GROUPE JAJ dropping 9.03% to €1.31 on Tuesday while CAC 40 slid 0.16% to €7,415.45.

Earnings Per Share

As for profitability, GROUPE JAJ has a trailing twelve months EPS of €0.24.

PE Ratio

GROUPE JAJ has a trailing twelve months price to earnings ratio of 5.46. Meaning, the purchaser of the share is investing €5.46 for every euro of annual earnings.

More news about GROUPE JAJ.

6. CASINO GUICHARD (CO.PA)

-8.82% Price Change

Casino, Guichard-Perrachon S.A. operates as a food retailer in France, Latin America, and internationally. The company operates hypermarkets, supermarkets, shopping malls, and e-commerce sites, as well as convenience, discount, and cash and carry stores. It also involved in banking, digital marketing, service station, franchise, real estate asset management, property development and trading, rental, banking, and energy-related activities. It operates through stores. The company was founded in 1898 and is based in Saint-Étienne, France.

CAC 40 ended the session with CASINO GUICHARD dropping 8.82% to €3.10 on Tuesday while CAC 40 slid 0.16% to €7,415.45.

Earnings Per Share

As for profitability, CASINO GUICHARD has a trailing twelve months EPS of €-3.34.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.53%.

Moving Average

CASINO GUICHARD’s worth is way under its 50-day moving average of €5.63 and way below its 200-day moving average of €8.51.

Revenue Growth

Year-on-year quarterly revenue growth grew by 9.3%, now sitting on 34B for the twelve trailing months.

Sales Growth

CASINO GUICHARD’s sales growth for the next quarter is negative 11.2%.

More news about CASINO GUICHARD.

7. ELIOR GROUP (ELIOR.PA)

-8.39% Price Change

Elior Group SA offers contract catering and support services in France and internationally. The company provides contract catering services to business and industry, education, and healthcare sectors under the Elior brand. It also offers a range of value-added services under the Elior Services brand, such as cleaning and hygiene services for hospitality, industrial premises, sales outlets, and agri-food industries; biological cleaning and hospitality services in the healthcare sector; and facility management services, including reception, mail management, minor maintenance, green areas, etc. The company operates approximately 20,250 restaurants and points of sale. Elior Group SA was founded in 1991 and is headquartered in Paris, France.

CAC 40 ended the session with ELIOR GROUP falling 8.39% to €2.60 on Tuesday while CAC 40 dropped 0.16% to €7,415.45.

Earnings Per Share

As for profitability, ELIOR GROUP has a trailing twelve months EPS of €-1.05.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -25.89%.

Volatility

ELIOR GROUP’s last week, last month’s, and last quarter’s current intraday variation average was 0.73%, 0.63%, and 2.03%.

ELIOR GROUP’s highest amplitude of average volatility was 2.07% (last week), 1.54% (last month), and 2.03% (last quarter).

More news about ELIOR GROUP.

8. NANOBIOTIX (NANO.PA)

-7.03% Price Change

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.

CAC 40 ended the session with NANOBIOTIX sliding 7.03% to €7.94 on Tuesday while CAC 40 fell 0.16% to €7,415.45.

Earnings Per Share

As for profitability, NANOBIOTIX has a trailing twelve months EPS of €-1.77.

Revenue Growth

Year-on-year quarterly revenue growth grew by 159.6%, now sitting on 4.78M for the twelve trailing months.

Volume

Today’s last reported volume for NANOBIOTIX is 630758 which is 70.69% above its average volume of 369523.

More news about NANOBIOTIX.

9. COHERIS (COH.PA)

-6.42% Price Change

Coheris SA provides customer relationship management (CRM) and analytics solutions in France and internationally. The company offers data solutions, such as digital and speech intelligence, cyber security, data science, data operating system, data mining and machine learning, and business intelligence and analytics. It also provides CRM customer service, sales force, and marketing; and unified commerce, including digital in-store, order management system, e-merchandising and searchandsing, wen-to-store, store management, unified stocks, returns and refunds, and clienteling, as well as product recommendation, seller performance optimization, look book, and digital asset management services. In addition, the company offers merchandising, and e-merchandising and search software; marketing automation; and last mile logistics services. It serves bank and finance, mutual insurance, consumer goods and GICs, retail, agrifood, OTC and pharmacy, out-of-home consumption, industry, luxury premium, audience, and regalian sectors. The company is based in Suresnes, France. Coheris SA is as subsidiary of ChapsVision.

CAC 40 ended the session with COHERIS sliding 6.42% to €5.10 on Tuesday while CAC 40 dropped 0.16% to €7,415.45.

Earnings Per Share

As for profitability, COHERIS has a trailing twelve months EPS of €0.78.

PE Ratio

COHERIS has a trailing twelve months price to earnings ratio of 6.54. Meaning, the purchaser of the share is investing €6.54 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 35.78%.

Volume

Today’s last reported volume for COHERIS is 6084 which is 2.51% below its average volume of 6241.

Yearly Top and Bottom Value

COHERIS’s stock is valued at €5.10 at 22:40 EST, way below its 52-week high of €6.10 and way higher than its 52-week low of €2.34.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, COHERIS’s stock is considered to be overbought (>=80).

Revenue Growth

Year-on-year quarterly revenue growth grew by 5.8%, now sitting on 13.84M for the twelve trailing months.

More news about COHERIS.

10. ACOMO (ACOMO.AS)

-6.31% Price Change

Acomo N.V., together with its subsidiaries, engages in sourcing, trading, processing, packaging, and distributing conventional and organic food ingredients and solutions for the food and beverage industry worldwide. It operates through five segments: Spices and Nuts, Edible Seeds, Organic Ingredients, Tea, and Food Solutions. The Spices and Nuts segment provides tropical products, including pepper, nutmeg, desiccated coconut, shelled and unshelled nuts, dried fruits, dehydrated vegetables, herbs, rice crackers, and snack products. Its Edible Seeds segment trades, processes, and distributes edible seeds, such as poppy, sesame, pumpkin, and flax, as well as sunflower seeds comprising in-kernel and shelled for the snack and retail industries; birdseeds for wildlife; and edible seeds to bakery, spice, and confectionery industries. The Organic Ingredients segment provides a range of organic food products and ingredients in various categories, including cocoa, coffee, fruit and vegetables, edible seeds, nuts and dried fruits, oils, and premium juice products. Its Tea segment trades, processes, and distributes through warehouses and blending facilities; and monitors and analyzes market development, and shares insight to customers to meet traditional consumer preferences, which include novel appetites for specialty tea. The Food Solutions segment produces and supplies culinary and functional ingredients, plant-based solutions, wet and dry blends, and spice mixes to food companies; and provides product development, manufacturing, packaging, distribution, and inventory management services. The company was formerly known as Amsterdam Commodities N.V. and changed its name to Acomo N.V. in June 2022. Acomo N.V. was founded in 1908 and is based in Rotterdam, the Netherlands.

AEX-Index ended the session with ACOMO sliding 6.31% to €20.80 on Tuesday while AEX-Index jumped 1.07% to €779.81.

Earnings Per Share

As for profitability, ACOMO has a trailing twelve months EPS of €1.85.

PE Ratio

ACOMO has a trailing twelve months price to earnings ratio of 11.24. Meaning, the purchaser of the share is investing €11.24 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.08%.

More news about ACOMO.

Stay up to date with our winners and losers daily report